Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

800
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
800
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449
Nonconscious Mimicry01:13

Nonconscious Mimicry

3.6K
Nonconscious mimicry occurs when individuals alter their mannerisms to match the behaviors and expressions of those nearby, without intention.
3.6K
The Placebo Effect01:54

The Placebo Effect

5.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
5.9K
The Influence of Affect on Cognition01:29

The Influence of Affect on Cognition

437
Positive affect significantly influences cognitive processes, including evaluation, memory, creativity, and social judgments. Compared to negative affect, positive emotional states promote more favorable interpretations of stimuli, cognitive flexibility, and heuristic processing. These effects highlight emotions' powerful role in shaping how individuals perceive, remember, and interact with the world.Influence on Evaluation and AttributionWhen individuals experience positive affect, they are...
437

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Setup and Positioning in Immediate Lymphatic Reconstruction.

Plastic and reconstructive surgery. Global open·2026
Same author

Small-molecule inhibitors of the protein kinase DYRK as potential therapeutic candidates in cancer.

Cell chemical biology·2026
Same author

A transcriptomic microglia taxonomy across mouse and human pathologies.

Nature immunology·2026
Same author

Non-invasive identification of brain signatures of acute liver injury.

Theranostics·2026
Same author

Longitudinal Characterization of Compound Action Potentials in Chronic Vagus Nerve Recordings in Mice.

International journal of neural systems·2026
Same author

Correction to: Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension.

Circulation research·2026

Related Experiment Video

Updated: May 3, 2026

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

17.6K

MIF: mood improving/inhibiting factor?

Joshua Bloom1, Yousef Al-Abed

  • 1Hofstra North Shore-LIJ School of Medicine, Hempstead, NY 11549, USA. jbloom2@nshs.edu.

Journal of Neuroinflammation
|January 23, 2014
PubMed
Summary

Major depressive disorder impacts many, yet its cause remains unclear. Macrophage migration inhibitory factor (MIF) shows complex roles in depression, offering potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Major depressive disorder (MDD) is a significant public health issue with unclear pathophysiology.
  • Inflammation and cytokines are increasingly recognized as relevant factors in depression research.
  • Macrophage migration inhibitory factor (MIF) has emerged as a key molecule in depression physiology.

Purpose of the Study:

  • To review current research on the role of MIF in depression.
  • To explore the dual role of MIF as both a pro- and antidepressant factor.
  • To discuss the therapeutic implications of targeting MIF for depression.

Main Methods:

  • Literature review of studies investigating MIF and its association with depression.
  • Analysis of research examining the biological functions of MIF in the context of mood disorders.

More Related Videos

Continuous Theta Burst Stimulation of the Posterior Medial Frontal Cortex to Experimentally Reduce Ideological Threat Responses
06:42

Continuous Theta Burst Stimulation of the Posterior Medial Frontal Cortex to Experimentally Reduce Ideological Threat Responses

Published on: September 28, 2018

14.3K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

21.9K

Related Experiment Videos

Last Updated: May 3, 2026

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

17.6K
Continuous Theta Burst Stimulation of the Posterior Medial Frontal Cortex to Experimentally Reduce Ideological Threat Responses
06:42

Continuous Theta Burst Stimulation of the Posterior Medial Frontal Cortex to Experimentally Reduce Ideological Threat Responses

Published on: September 28, 2018

14.3K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

21.9K
  • Synthesis of evidence regarding MIF's influence on depressive symptoms and pathophysiology.

    • Main Results:

    • MIF exhibits complex and sometimes contradictory effects on depression.
    • Evidence suggests MIF can act as both a pro-depressant and an anti-depressant factor.
    • MIF levels and activity are significantly altered in individuals with major depressive disorder.

    Conclusions:

    • MIF is a critical player in the pathophysiology of major depressive disorder.
    • Understanding MIF's dual role is essential for developing effective depression treatments.
    • Targeting MIF presents a promising therapeutic strategy for major depressive disorder.